These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25262449)

  • 1. Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition.
    Ahmed TA; Hayslip J; Leggas M
    Leuk Res; 2014 Nov; 38(11):1350-7. PubMed ID: 25262449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.
    Pelaia G; Gallelli L; Renda T; Fratto D; Falcone D; Caraglia M; Busceti MT; Terracciano R; Vatrella A; Maselli R; Savino R
    Cell Prolif; 2012 Dec; 45(6):557-65. PubMed ID: 23045963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected].
    Geryk-Hall M; Yang Y; Hughes DP
    Mol Cancer Ther; 2010 May; 9(5):1111-9. PubMed ID: 20406948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.
    Ding H; McDonald JS; Yun S; Schneider PA; Peterson KL; Flatten KS; Loegering DA; Oberg AL; Riska SM; Huang S; Sinicrope FA; Adjei AA; Karp JE; Meng XW; Kaufmann SH
    Haematologica; 2014 Jan; 99(1):60-9. PubMed ID: 23996484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in simvastatin-induced cytotoxicity in AML is caused by differences in Ras-isoprenylation.
    van der Weide K; Korthuis PM; Kuipers F; de Vries EG; Vellenga E
    Leukemia; 2012 Apr; 26(4):845-8. PubMed ID: 21931323
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation.
    Dai Y; Khanna P; Chen S; Pei XY; Dent P; Grant S
    Blood; 2007 May; 109(10):4415-23. PubMed ID: 17264303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
    J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.
    van der Weide K; de Jonge-Peeters SD; Kuipers F; de Vries EG; Vellenga E
    Clin Cancer Res; 2009 May; 15(9):3076-83. PubMed ID: 19383813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin suppresses coronary artery endothelial tube formation by disrupting Ras/Raf/ERK signaling.
    Miura S; Matsuo Y; Saku K
    Atherosclerosis; 2004 Aug; 175(2):235-43. PubMed ID: 15262179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line].
    Ren H; Zhang N; Xu H; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):72-5. PubMed ID: 11877052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
    Qi XF; Zheng L; Lee KJ; Kim DH; Kim CS; Cai DQ; Wu Z; Qin JW; Yu YH; Kim SK
    Cell Death Dis; 2013 Feb; 4(2):e518. PubMed ID: 23449454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways.
    Tsubaki M; Fujiwara D; Takeda T; Kino T; Tomonari Y; Itoh T; Imano M; Satou T; Sakaguchi K; Nishida S
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):222-234. PubMed ID: 27805296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2+ influx through plasma membrane Ca2+ channels.
    Yanamandra N; Buzzeo RW; Gabriel M; Hazlehurst LA; Mari Y; Beaupre DM; Cuevas J
    J Pharmacol Exp Ther; 2011 Jun; 337(3):636-43. PubMed ID: 21378206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
    Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
    Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells.
    Kobayashi K; Baba K; Kambayashi S; Okuda M
    Vet Comp Oncol; 2021 Mar; 19(1):99-108. PubMed ID: 32779819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines.
    Medeiros BC; Landau HJ; Morrow M; Lockerbie RO; Pitts T; Eckhardt SG
    Leukemia; 2007 Apr; 21(4):739-46. PubMed ID: 17268526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.